PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Yeah, apologies, I think we are at crossed wires in saying the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,730 Posts.
    lightbulb Created with Sketch. 6993
    Yeah, apologies, I think we are at crossed wires in saying the same thing, i.e. the January expenditure indicated by today's report not quite as surprising some seem to think above.

    The $6M indicated January spend from the reported balance in fact in keeping or even perhaps less (given higher initial outlay expenses reported) than the $8 - $11M (including R&D refund) qtrly spend guidance (i.e. $15.5 - 18.5M spend guidance excluding refund).

    Perhaps explaining the (relief?) rally today - PAR having blown out on previous guidance.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.